Citations

Clear

2391 citation(s) found for "Ma, Lin".

A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
Aglago, Elom K. , Kim, Andre E. , Lin, Yi , Qu, Conghui , Evangelou, Marina , Yu, Ren , Morrison, John L. , Albanes, Demetrius , Arndt, Volker , Barry, Elizabeth L. , Baurley, James W. , Berndt, Sonja I. , Bishop, D. Timothy , Bouras, Emmanouil , Brenner, Hermann , Casey, Graham , Chang‐Claude, Jenny , Díez‐Obrero, Virginia , Figueiredo, Jane C. , Gallinger, Steven , Gruber, Stephen B. , Gsur, Andrea , Harlid, Sophia , Harrison, Tabitha A. , Hoffmeister, Michael , Huyghe, Jeroen R. , Jordahl, Kristina M. , Joshi, Amit D. , Kundaje, Anshul , Li, Li , Mandic, Marko , Obón‐Santacana, Mireia , Nan, Hongmei , Nassir, Rami , Ose, Jennifer , Pai, Rish K. , Papadimitriou, Nikos , Prentice, Ross L. , Scacheri, Peter C. , Schmit, Stephanie L. , Slattery, Martha L. , Thibodeau, Stephen N. , Thomas, Duncan C. , Duijnhoven, Fränzel J.B. van , Guelpen, Bethany Van , Visvanathan, Kala , Vodička, Pavel , White, Emily , Woods, Michael O. , Wu, Anna H. , Zemlianskaia, Natalia , Gauderman, W. James , Peters, Ulrike , Kim, Andre E , Ren, Yu , Morrison, John L , Bien, Stephanie A , Bishop, D Timothy , Bouras, Emmanouil , Brenner, Hermann , Buchanan, Daniel D , Budiarto, Arif , Carreras-Torres, Robert , Casey, Graham , Cenggoro, Tjeng Wawan , Chan, Andrew T , Chang-Claude, Jenny , Chen, Xuechen , Conti, David V , Devall, Matthew A M , Diez-Obrero, Virginia , Dimou, Niki , Drew, David A , Figueiredo, Jane C , Gallinger, Steven , Giles, Graham G , Gruber, Stephen B , Gsur, Andrea , Gunter, Marc J , Hampel, Heather , Harlid, Sophia , Hidaka, Akihisa , Harrison, Tabitha A , Hoffmeister, Michael , Huyghe, Jeroen R , Jenkins, Mark A , Jordahl, Kristina M , Joshi, Amit D , Kawaguchi, Eric , Keku, Temitope O , Kundaje, Anshul , Larsson, Susanna C , Marchand, Loïc Le , Lewinger, Juan Pablo , Li, Li , Lynch, Brigid M , Mahesworo, Bharuno , Mandic, Marko , Obón-Santacana, Mireia , Moreno, Victor , Murphy, Neil , Nan, Hongmei , Nassir, Rami , Newcomb, Polly A. , Ogino, Shuji , Ose, Jennifer , Pai, R K , Palmer, Julie R , Papadimitriou, Nikos , Pardamean, Bens , Peoples, Anita R , Platz, Elizabeth A. , Potter, John D , Prentice, Ross L , Rennert, Gad , Ruiz-Narvaez, Edward , Sakoda, Lori C , Scacheri, Peter C , Schmit, Stephanie L , Schoen, Robert E , Shcherbina, Anna , Slattery, Martha L , Stern, Mariana Carla , Su, Yu-Ru , Tangen, Catherine M , Thibodeau, Stephen N , Thomas, Duncan C , Tian, Yu , Ulrich, Cornelia M , van Duijnhoven, Fränzel J B , Van Guelpen, Bethany , Visvanathan, Kala , Vodicka, Pavel , Wang, Jun , White, Emily , Wolk, Alicja , Woods, Michael O , Wu, Anna H. , Zemlianskaia, Natalia , Hsu, Li , Gauderman, W James , Peters, Ulrike , Tsilidis, Konstantinos K , Campbell, Peter T , Arndt, Volker , Aglago, Elom K , Albanes, Demetrius , Qu, Conghui , Bien, Stephanie A. , Buchanan, Daniel D. , Carreras‐Torres, Robert , Chan, Andrew T. , Conti, David V. , Dimou, Niki , Drew, David A. , Giles, Graham G. , Gunter, Marc J. , Hampel, Heather , Hidaka, Akihisa , Jenkins, Mark A. , Larsson, Susanna C. , Marchand, Loı̈c Le , Lewinger, Juan Pablo , Moreno, Vı́ctor , Murphy, Neil , Palmer, Julie R. , Pardamean, Bens , Potter, John D. , Rennert, Gad , Sakoda, Lori C. , Schoen, Robert E. , Shcherbina, Anna , Tangen, Catherine M. , Tian, Yu , Ulrich, Cornelia M. , Wolk, Alicja , Tsilidis, Konstantinos K. , Campbell, Peter T.

Mayo Clinic

Cancer Research | May 30, 2023 | Volume: 83 | Issue: 15 | Pages: 2572-2583

10.1158/0008-5472.can-22-3713 | PMID 37249599 Get It

Abstract Colorectal cancer risk can be impacted by genetic, environmental, and lifestyle factors, including diet and obesity. Gene-environment interactions (G × E) can provide biological insights into the effects of obesity on colorectal cancer risk. Here, we assessed potential genome-wide G × E interactions between body mass index (BMI) and common SNPs for colorectal cancer risk using data from 36,415 colorectal cancer cases and 48,451 controls from three international colorectal cancer consortia (CCFR, CORECT, and GECCO). The G × E tests included the conventional logistic regression using multiplicative terms (one degree of freedom, 1DF test), the two-step EDGE method, and the joint 3DF test, each of which is powerful for detecting G × E interactions under specific conditions. BMI was associated with higher colorectal cancer risk. The two-step approach revealed a statistically significant G×BMI interaction located within the Formin 1/Gremlin 1 (FMN1/GREM1) gene region (rs58349661). This SNP was also identified by the 3DF test, with a suggestive statistical significance in the 1DF test. Among participants with the CC genotype of rs58349661, overweight and obesity categories were associated with higher colorectal cancer risk, whereas null associations were observed across BMI categories in those with the TT genotype. Using data from three large international consortia, this study discovered a locus in the FMN1/GREM1 gene region that interacts with BMI on the association with colorectal cancer risk. Further studies should examine the potential mechanisms through which this locus modifies the etiologic link between obesity and colorectal cancer. Significance: This gene-environment interaction analysis revealed a genetic locus in FMN1/GREM1 that interacts with body mass index in colorectal cancer risk, suggesting potential implications for precision prevention strategies.
SPIN-AI: A Deep Learning Model That Identifies Spatially Predictive Genes
Meng-Lin, Kevin, Ung, Choong-Yong, Zhang, Cheng , Weiskittel, Taylor M. , Wiśniewski, P., Zhang, Z M , Tan, Shyang-Hong, Yeo, Kok Siong , Zhu, Shizhen , Wisniewski, Philip , Zhang, Zhuofei, Correia, Cristina , Li, Hu

Mayo Clinic

Biomolecules | May 27, 2023 | Volume: 13 | Issue: 6 | Pages: 895

10.3390/biom13060895 | PMID 37371475 Get It

Spatially resolved sequencing technologies help us dissect how cells are organized in space. Several available computational approaches focus on the identification of spatially variable genes (SVGs), genes whose expression patterns vary in space. The detection of SVGs is analogous to the identification of differentially expressed genes and permits us to understand how genes and associated molecular processes are spatially distributed within cellular niches. However, the expression activities of SVGs fail to encode all information inherent in the spatial distribution of cells. Here, we devised a deep learning model, Spatially Informed Artificial Intelligence (SPIN-AI), to identify spatially predictive genes (SPGs), whose expression can predict how cells are organized in space. We used SPIN-AI on spatial transcriptomic data from squamous cell carcinoma (SCC) as a proof of concept. Our results demonstrate that SPGs not only recapitulate the biology of SCC but also identify genes distinct from SVGs. Moreover, we found a substantial number of ribosomal genes that were SPGs but not SVGs. Since SPGs possess the capability to predict spatial cellular organization, we reason that SPGs capture more biologically relevant information for a given cellular niche than SVGs. Thus, SPIN-AI has broad applications for detecting SPGs and uncovering which biological processes play important roles in governing cellular organization.
Pericardial late gadolinium enhancement and time to recurrence: a substudy from RHAPSODY, a phase 3 clinical trial of rilonacept in recurrent pericarditis
Lin, David , Abbate, Antonio , Jellis, Christine , Kwon, Debbie, Brucato, Antonio, Fang, Fang , LeWinter, Martin M. , Zou, Liangxing, Paolini, John F. , Investigators, RHAPSODY, Abo‐Auda, Wael, Akhtar, Asif, Arad, Michael , Baibhav, Bipul, Bhalla, Karan, Brucato, Antonio, Cross, David, Eisen, Alon , FREEDBERG, NAHUM A., Fuchs, Shmuel, Gaddam, Eliyazar, Gelfand, Eli V. , Grena, Paul, Halabi, Majdi , Harris, David C.H. , Karim, Amin, Kontzias, Apostolos , Kornberg, Robert, Latif, Faisal , Leibowitz, David , Lou, Pey Wen, Moriel, Mady , Roberts‐Thomson, Philip , Schiff, Elad , Siegel, Robert , Stokes, Michael B. , Sutej, Paul, Wittekind, Samuel G. , Witzling, Valentin, Cremer, Paul , Luis, Sushil Allen , Petersen, John W. , KWON, DEBBIE H., Brucato, Antonio, Insalaco, Antonella , Lewis, Basil S. , Nicholls, Stephen J. , Klein, Allan L. , Imazio, Massimo , Investigators, RHAPSODY, Atar, Shaul , Brucato, Antonio, Collins, Sean P. , Colquhoun, David Martin , Dwivedi, Girish , Gattorno, Marco , Karim, Amin, Knowlton, Kirk U. , Lotan, Dor , Portman, Michael A. , Schiff, Elad, Siegel, Robert, Zukermann, Robert

Mayo Clinic

European Heart Journal - Imaging Methods and Practice | May 26, 2023 | Volume: 1 | Issue: 1 | Pages: No page available

10.1093/ehjimp/qyad003 | PMID 39044797 Get It

Abstract Aims In this protocol-predefined substudy of the RHAPSODY trial, the primary aim was to assess whether pericardial late gadolinium enhancement (LGE) was associated with time to pericarditis recurrence. Methods and results RHAPSODY was a Phase 3 double-blind, placebo-controlled, randomized-withdrawal trial that demonstrated the efficacy of rilonacept in recurrent pericarditis (RP). Patients with a history of multiple RP and an active recurrence were enrolled and had the option to participate in a cardiac magnetic resonance (CMR) imaging substudy. CMRs were interpreted by a blinded independent core laboratory with prespecified criteria to define pericardial LGE. Compared to patients with trace or mild pericardial LGE (n = 9), patients with moderate or severe pericardial LGE (n = 16) generally had a higher number of recurrent episodes per year (5.3 vs. 3.9) and a higher mean CRP level (3.6 vs. 1.1 mg/dL). Overall, 10/14 (71.4%) who received a placebo had a recurrence compared to 0/11 (0%) who received rilonacept. In patients randomized to placebo who had moderate or severe pericardial LGE, the median time to recurrence was 4.2 weeks compared to 10.7 weeks in patients who had trace or mild pericardial LGE. At the conclusion of the event-driven randomized-withdrawal period, among patients receiving a placebo, 5/7 (71.4%) with trace or mild pericardial LGE and 5/7 (71.4%) with moderate or severe pericardial LGE had a recurrence. Conclusions Among patients with multiple RP, these preliminary findings support the concept of pericardial LGE as an imaging biomarker that may inform the duration of treatment and risk of recurrence with cessation of therapy and larger studies should be considered. ClinicalTrials.gov Identifier NCT03737110
Impact of statins based on high-risk plaque features on coronary plaque progression in mild stenosis lesions: results from the PARADIGM study
Sung, Ji Min , Lee, Byoung Kwon , Lin, Fay Y. , Hadamitzky, Martin , Kim, Yong‐Jin , Andreini, Daniele , Pontone, Gianluca , Chun, Eun Ju , Cademartiri, Filippo , Maffei, Erica , Marques, Hugo , Leipsic, Jonathon , Choi, Jung Hyun , Virmani, Renu , Samady, Habib , Chinnaiyan, Kavitha M. , Stone, Peter H. , Berman, Daniel S. , Shaw, Leslee J. , Min, James K. , Chang, Hyuk‐Jae , Cademartiri, Filippo , Virmani, Renu , Chang, Hyuk-Jae , Park, Hyung‐Bok , Arsanjani, Reza , Heo, Ran , Conte, Edoardo , Budoff, Matthew J. , Gottlieb, Ilan , Gonçalves, Pedro de Araújo , Lee, Sang‐Eun , Shin, Sanghoon , Narula, Jagat , Bax, Jeroen J.

Mayo Clinic

European Heart Journal - Cardiovascular Imaging | May 26, 2023 | Volume: 24 | Issue: 11 | Pages: 1536-1543

10.1093/ehjci/jead110 | PMID 37232393 Get It

Abstract Aims To investigate the impact of statins on plaque progression according to high-risk coronary atherosclerotic plaque (HRP) features and to identify predictive factors for rapid plaque progression in mild coronary artery disease (CAD) using serial coronary computed tomography angiography (CCTA). Methods and results We analyzed mild stenosis (25–49%) CAD, totaling 1432 lesions from 613 patients (mean age, 62.2 years, 63.9% male) and who underwent serial CCTA at a ≥2 year inter-scan interval using the Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging (NCT02803411) registry. The median inter-scan period was 3.5 ± 1.4 years; plaques were quantitatively assessed for annualized percent atheroma volume (PAV) and compositional plaque volume changes according to HRP features, and the rapid plaque progression was defined by the ≥90th percentile annual PAV. In mild stenotic lesions with ≥2 HRPs, statin therapy showed a 37% reduction in annual PAV (0.97 ± 2.02 vs. 1.55 ± 2.22, P = 0.038) with decreased necrotic core volume and increased dense calcium volume compared to non-statin recipient mild lesions. The key factors for rapid plaque progression were ≥2 HRPs [hazard ratio (HR), 1.89; 95% confidence interval (CI), 1.02–3.49; P = 0.042], current smoking (HR, 1.69; 95% CI 1.09–2.57; P = 0.017), and diabetes (HR, 1.55; 95% CI, 1.07–2.22; P = 0.020). Conclusion In mild CAD, statin treatment reduced plaque progression, particularly in lesions with a higher number of HRP features, which was also a strong predictor of rapid plaque progression. Therefore, aggressive statin therapy might be needed even in mild CAD with higher HRPs. Clinical trial registration ClinicalTrials.gov NCT02803411
2023 HRS/EHRA/APHRS/LAHRS Expert Consensus Statement on Practical Management of the Remote Device Clinic
Ferrick, Aileen M., Kojodjojo, Pipin , López-Cabanillas, Néstor , Chew, Derek S. , Choi, Jong‐Il , Dagres, Nikolaos , Dalal, Aarti , Dechert, Brynn E. , Frazier‐Mills, Camille, Gilbert, Olivia , Hewit, Sherri, Kneeland, Christine , Mirza, Starr DeEllen, Runté, Mary, Sinclair, Susan, Teixeira, Ricardo Alkmim , Vandenberk, Bert , Davenport, Elizabeth , Freedenberg, Vicki , Glotzer, Taya V. , Ikeda, Takanori , Kramer, Daniel B. , Lin, David , Rojel-Martínez, Ulises, Stühlinger, Markus , Varosy, Paul D. , Dagres, Nikolaos , Raj, Satish R , Deneke, Thomas , Abe, Haruhiko , Bovéda, Serge , Han, Janet K. , Hewit, Sherri, Mittal, Suneet , Ricci, Renato Pietro , Teixeira, Ricardo Alkmim , Vandenberk, Bert , Varma, Niraj , Huang, Jin‐Long

Mayo Clinic

Europace | May 20, 2023 | Volume: 25 | Issue: 5 | Pages: No page available

10.1093/europace/euad123 | PMID 37208301 Get It

Abstract Remote monitoring is beneficial for the management of patients with cardiovascular implantable electronic devices by impacting morbidity and mortality. With increasing numbers of patients using remote monitoring, keeping up with higher volume of remote monitoring transmissions creates challenges for device clinic staff. This international multidisciplinary document is intended to guide cardiac electrophysiologists, allied professionals, and hospital administrators in managing remote monitoring clinics. This includes guidance for remote monitoring clinic staffing, appropriate clinic workflows, patient education, and alert management. This expert consensus statement also addresses other topics such as communication of transmission results, use of third-party resources, manufacturer responsibilities, and programming concerns. The goal is to provide evidence-based recommendations impacting all aspects of remote monitoring services. Gaps in current knowledge and guidance for future research directions are also identified.
2023 HRS/EHRA/APHRS/LAHRS Expert Consensus Statement on Practical Management of the Remote Device Clinic
Ferrick, Aileen M., Kojodjojo, Pipin , López-Cabanillas, Néstor , Chew, Derek S. , Choi, Jong‐Il , Dagres, Nikolaos , Dalal, Aarti , Dechert, Brynn E. , Frazier‐Mills, Camille, Gilbert, Olivia , Hewit, Sherri, Kneeland, Christine , Mirza, Starr DeEllen, Runté, Mary, Sinclair, Susan, Teixeira, Ricardo Alkmim , Vandenberk, Bert , Reviewers, Document, Davenport, Elizabeth , Freedenberg, Vicki , Glotzer, Taya V. , Ikeda, Takanori , Kramer, Daniel B. , Lin, David , Rojel‐Martínez, Ulises, Stühlinger, Markus , Varosy, Paul D. , Huang, Jin-Long, Rojel-Martínez, Ulises, Dagres, Nikolaos , Raj, Satish R , Deneke, Thomas , Abe, Haruhiko , Bovéda, Serge , Han, Janet K. , Mittal, Suneet , Ricci, Renato Pietro , Teixeira, Ricardo Alkmim , Vandenberk, Bert , Varma, Niraj , Reviewers, Document, Huang, Jin‐Long

Mayo Clinic

Journal of Arrhythmia | May 19, 2023 | Volume: 39 | Issue: 3 | Pages: 250-302

10.1002/joa3.12851 | PMID 37324757 Get It

AbstractRemote monitoring is beneficial for the management of patients with cardiovascular implantable electronic devices by impacting morbidity and mortality. With increasing numbers of patients using remote monitoring, keeping up with higher volume of remote monitoring transmissions creates challenges for device clinic staff. This international multidisciplinary document is intended to guide cardiac electrophysiologists, allied professionals, and hospital administrators in managing remote monitoring clinics. This includes guidance for remote monitoring clinic staffing, appropriate clinic workflows, patient education, and alert management. This expert consensus statement also addresses other topics such as communication of transmission results, use of third‐party resources, manufacturer responsibilities, and programming concerns. The goal is to provide evidence‐based recommendations impacting all aspects of remote monitoring services. Gaps in current knowledge and guidance for future research directions are also identified.
American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation
Chey, William D. , Imdad, Aamer , Almario, Christopher V. , Bharucha, Adil E. , Diem, Susan J. , Greer, Katarina B. , Hanson, Brian, Harris, Lucinda A. , Ko, Cynthia W. , Patel, Amit , Shah, Eric D. , Sultan, Shahnaz , Patel, A , Imdad, Aamer , Shah, Eric D , Chang, Lin , Murad, M. Hassan , Lembo, Anthony

Mayo Clinic

American Journal of Gastroenterology | May 19, 2023 | Volume: 118 | Issue: 6 | Pages: 936-954

10.14309/ajg.0000000000002227 | PMID 37204227 Get It

INTRODUCTION: Chronic idiopathic constipation (CIC) is a common disorder associated with significant impairment in quality of life. This clinical practice guideline, jointly developed by the American Gastroenterological Association and the American College of Gastroenterology, aims to inform clinicians and patients by providing evidence-based practice recommendations for the pharmacological treatment of CIC in adults. METHODS: The American Gastroenterological Association and the American College of Gastroenterology formed a multidisciplinary guideline panel that conducted systematic reviews of the following agents: fiber, osmotic laxatives (polyethylene glycol, magnesium oxide, lactulose), stimulant laxatives (bisacodyl, sodium picosulfate, senna), secretagogues (lubiprostone, linaclotide, plecanatide), and serotonin type 4 agonist (prucalopride). The panel prioritized clinical questions and outcomes and used the Grading of Recommendations Assessment, Development, and Evaluation framework to assess the certainty of evidence for each intervention. The Evidence to Decision framework was used to develop clinical recommendations based on the balance between the desirable and undesirable effects, patient values, costs, and health equity considerations. RESULTS: The panel agreed on 10 recommendations for the pharmacological management of CIC in adults. Based on available evidence, the panel made strong recommendations for the use of polyethylene glycol, sodium picosulfate, linaclotide, plecanatide, and prucalopride for CIC in adults. Conditional recommendations were made for the use of fiber, lactulose, senna, magnesium oxide, and lubiprostone. DISCUSSION: This document provides a comprehensive outline of the various over-the-counter and prescription pharmacological agents available for the treatment of CIC. The guidelines are meant to provide a framework for approaching the management of CIC; clinical providers should engage in shared decision making based on patient preferences as well as medication cost and availability. Limitations and gaps in the evidence are highlighted to help guide future research opportunities and enhance the care of patients with chronic constipation.
Network Biology-Inspired Machine Learning Features Predict Cancer Gene Targets and Reveal Target Coordinating Mechanisms
Weiskittel, Taylor M. , Cao, Andrew, Meng-Lin, Kevin, Lehmann, Zachary , Feng, Benjamin, Wisniewski, P. , Zhu, Shizhen , Ung, Choong Yong , Wisniewski, Philip , Zhu, Shizhen , Yong Ung, Choong, Cao, Andrew, Correia, Cristina , Zhang, Cheng , Li, Hu

Mayo Clinic

Pharmaceuticals | May 17, 2023 | Volume: 16 | Issue: 5 | Pages: 752

10.3390/ph16050752 | PMID 37242535 Get It

Anticipating and understanding cancers’ need for specific gene activities is key for novel therapeutic development. Here we utilized DepMap, a cancer gene dependency screen, to demonstrate that machine learning combined with network biology can produce robust algorithms that both predict what genes a cancer is dependent on and what network features coordinate such gene dependencies. Using network topology and biological annotations, we constructed four groups of novel engineered machine learning features that produced high accuracies when predicting binary gene dependencies. We found that in all examined cancer types, F1 scores were greater than 0.90, and model accuracy remained robust under multiple hyperparameter tests. We then deconstructed these models to identify tumor type-specific coordinators of gene dependency and identified that in certain cancers, such as thyroid and kidney, tumors’ dependencies are highly predicted by gene connectivity. In contrast, other histologies relied on pathway-based features such as lung, where gene dependencies were highly predictive by associations with cell death pathway genes. In sum, we show that biologically informed network features can be a valuable and robust addition to predictive pharmacology models while simultaneously providing mechanistic insights.